Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: Int J Cancer. 2018 Dec 19;144(7):1496–1510. doi: 10.1002/ijc.31653

Table 3.

Hazard ratios and 95% confidence intervals of subgroups of fruit and vegetable consumption in relation to incident invasive breast cancer (n=10,911 cases) in Nurses’ Health Study and Nurses’ Health Study II.

Consumption Levels Ptrend
Green leafy vegetable intake
Amount of intake ≤2 servings/week >2 to 4 servings/week >4 to 6 servings/week >6 servings/week to 1 serving/day >1 servings/day
  No. of cases/person-years in NHS 1,500/567,610 2,163/659,719 1,848/534,085 723/213,002 1,367/372,934
  No. of cases/person-years in NHSII 604/403,641 870/538,425 757/415,130 284/177,224 785/419,358
 Model 1 1 1.02 (0.96–1.08) 1.02 (0.96–1.09) 1.02 (0.94–1.10) 1.04 (0.98–1.11) 0.28
 Model 2 1 0.95 (0.90–1.01) 0.93 (0.87–0.99) 0.92 (0.85–0.99) 0.93 (0.87–0.99) 0.03

Yellow/orange vegetable intake

Amount of intake ≤2 servings/week >2 to 3 servings/week >3 to 4 servings/week >4 to 5 servings/week >5 servings/week
  No. of cases/person-years in NHS 4,108/1,305,886 1,657/470,261 931/293,064 457/129,100 458/156,630
  No. of cases/person-years in NHSII 1,953/1,188,668 631/352,322 361/191,770 154/104,970 201/116,123
 Model 1 1 1.00 (0.95–1.05) 0.96 (0.91–1.02) 0.94 (0.87–1.02) 0.90 (0.83–0.98) 0.007
 Model 2 1 0.98 (0.93–1.03) 0.95 (0.89–1.01) 0.93 (0.85–1.01) 0.91 (0.84–0.99) 0.004

Tomato intake

Amount of intake ≤2 servings/week >2 to 4 servings/week >4 to 6 servings/week >6 servings/week to 1 serving/day >1 servings/day
  No. of cases/person-years in NHS 1,675/595,564 3,132/950,188 1,815/518,863 498/157,262 479/128,381
  No. of cases/person-years in NHSII 750/511,096 1,197/658,061 794/456,451 202/115,244 357/212,870
 Model 1 1 1.05 (1.00–1.11) 1.07 (1.01–1.13) 1.05 (0.96–1.14) 1.11 (1.02–1.20) 0.009
 Model 2 1 1.02 (0.97–1.07) 1.03 (0.97–1.09) 1.02 (0.93–1.11) 1.06 (0.98–1.15) 0.21

Cruciferous vegetable intake

Amount of intake ≤2 servings/week >2 to 3 servings/week >3 to 4 servings/week >4 to 5 servings/week >5 servings/week
  No. of cases/person-years in NHS 3,030/1,024,004 1,729/476,923 1,190/364,159 705/192,392 955/297,017
  No. of cases/person-years in NHSII 1,458/880,950 681/385,353 466/262,993 281/161,688 414/262,876
 Model 1 1 1.01 (0.96–1.06) 0.95 (0.89–1.00) 0.97 (0.90–1.04) 0.91 (0.85–0.96) 0.0007
 Model 2 1 0.97 (0.92–1.02) 0.92 (0.87–0.98) 0.94 (0.87–1.01) 0.90 (0.84–0.96) 0.0002

Other vegetable intake
Amount of intake ≤2 servings/week >2 to 4 servings/week >4 to 6 servings/week >6 servings/week to 1 serving/day >1 servings/day
  No. of cases/person-years in NHS 554/222,662 2,183/694,458 2,286/681,612 912/264,363 1,676/491,969
  No. of cases/person-years in NHSII 251/154,205 821/490,953 905/504,966 320/194,177 1,003/609,606
 Model 1 1 1.03 (0.96–1.12) 1.03 (0.95–1.11) 1.04 (0.95–1.13) 0.99 (0.91–1.07) 0.17
 Model 2 1 0.99 (0.92–1.07) 0.98 (0.90–1.06) 0.99 (0.90–1.08) 0.94 (0.86–1.02) 0.06

Fruits and vegetables high in vitamin C

Amount of intake ≤2 servings/week >2 to 4 servings/week >4 to 6 servings/week >6 servings/week to 1 serving/day >1 servings/day
  No. of cases/person-years in NHS 821/322,755 1,787/566,451 1,836/548,713 825/229,135 2,342/688,031
  No. of cases/person-years in NHSII 444/271,768 954/577,239 823/468,741 286/164,045 793/472,149
 Model 1 1 0.99 (0.92–1.06) 0.97 (0.91–1.04) 1.02 (0.94–1.10) 0.94 (0.88–1.00) 0.04
 Model 2 1 0.94 (0.87–1.00) 0.91 (0.85–0.97) 0.95 (0.87–1.03) 0.89 (0.82–0.95) 0.004

Fruits and vegetables high in α-carotene

Amount of intake <2 servings/month 2 to <4 servings/month 1 to <2 servings/week 2 to <3 servings/week ≥3 servings/week
  No. of cases/person-years in NHS 665/191,717 2,070/649,455 2,586/802,189 1,123/316,909 1,162/391,617
  No. of cases/person-years in NHSII 451/284,886 889/529,046 1,033/599,456 471/266,650 456/273,655
 Model 1 1 0.95 (0.89–1.02) 0.94 (0.88–1.00) 0.92 (0.85–0.99) 0.91 (0.84–0.98) 0.01
 Model 2 1 0.95 (0.88–1.01) 0.92 (0.86–0.99) 0.89 (0.82–0.96) 0.91 (0.84–0.99) 0.02

Fruits and vegetables high in β-carotene

Amount of intake ≤2 servings/week >2 to 4 servings/week >4 to 6 servings/week >6 servings/week to 1 serving/day >1 servings/day
  No. of cases/person-years in NHS 736/301,972 1,381/455,777 1,697/508,135 851/241,899 2,946/847,277
  No. of cases/person-years in NHSII 249/173,435 612/379,126 696/414,291 324/186,699 1,419/800,339
 Model 1 1 1.01 (0.93–1.09) 1.00 (0.93–1.08) 1.04 (0.95–1.13) 1.00 (0.93–1.07) 0.66
 Model 2 1 0.94 (0.86–1.01) 0.90 (0.83–0.98) 0.92 (0.84–1.01) 0.87 (0.80–0.94) 0.0004

Fruits and vegetables high in lutein

Amount of intake ≤1 serving/month >1 to 3 servings/month >3 to 4 servings/month >1 to 3 servings/week >3 servings/week
  No. of cases/person-years in NHS 797/254,275 1,944/581,492 1,410/457,320 2,820/820,986 630/233,258
  No. of cases/person-years in NHSII 861/565,092 1,084/622,253 492/299,831 723/389,612 140/76,717
 Model 1 1 1.04 (0.98–1.11) 1.03 (0.97–1.11) 1.04 (0.98–1.10) 0.98 (0.89–1.07) 0.39
 Model 2 1 1.01 (0.95–1.07) 1.00 (0.93–1.07) 0.97 (0.92–1.04) 0.94 (0.86–1.03) 0.07

Model 1 stratified by cohort, calendar year, and age in months.

Model 2 stratified by cohort, calendar year, and age in months and adjusted for family history of breast cancer (yes, no), history of benign breast disease (yes, no), height (<1.60, 1.60 to <1.65, 1.65 to <1.70, 1.70 to <1.75, and ≥1.75 meters), BMI at age 18 years (<18.5, 18.5 to <20, 20 to <22.5, 22.5 to <25, 25.0 to <30, ≥30.0 kg/m2), weight change since age 18 (continuous), smoking (never, past, current 1 to 14/day, current 15 to 24/day, current ≥25/day), physical activity (quintiles of MET-hr per week, missing), oral contraceptive use (never, < 2 years, 2 to <5 years, 5 to <10 years, ≥10 years), alcohol intake (g/day, quintiles), total energy intake (kcal/day, quintiles), age at menarche (<12, 12, 13, 14, >14 years), parity and age at first birth (nulliparous, parity ≤2 and age at first birth <25 years, parity≤2 and age at first birth 25 to <30 years, parity ≤2 and age at first birth ≥30 years, parity 3 to 4 and age at first birth <25 years, parity 3 to 4 and age at first birth 25 to <30 years, parity 3 to 4 and age at first birth ≥30 years, parity ≥5 and age at first birth <25 years, parity ≥5 and age at first birth ≥25 years), and menopausal status, age at menopause, and postmenopausal hormone use (premenopausal, postmenopausal and age at menopause<50 years and never postmenopausal hormone use, postmenopausal and age at menopause<50 years and past postmenopausal hormone use, postmenopausal and age at menopause<50 years and current postmenopausal hormone use, postmenopausal and age at menopause≥50 years and never postmenopausal hormone use, postmenopausal and age at menopause≥50 years and past postmenopausal hormone use, postmenopausal and age at menopause≥50 years and current postmenopausal hormone use, missing).